Clostridium Difficile-associated Diarrhea (CDAD)
5 clinical trials · Condition
◉ Watch Clostridium Difficile-associated Diarrhea (CDAD)
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) (NCT02218372) | Astellas Pharma Europe B.V. | 2015-01-09 |
| Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001) (NCT01691248) | Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-10-10 |
| A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009) (NCT02835118) | Merck Sharp & Dohme LLC | 2009-07-01 |
| A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008) (NCT02835105) | Merck Sharp & Dohme LLC | 2009-01-01 |
| IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff (NCT00177970) | University of Pittsburgh | 2003-10-01 |
Track Clostridium Difficile-associated Diarrhea (CDAD) automatically
Every clearance here is in the API, with alerts when new ones post.